Ranbaxy taking drugs to US, UK for trials
Facebook Twitter google+ RSS Feed

Ranbaxy taking drugs to US, UK for trials

By SiliconIndia   |   Thursday, 25 September 2003, 07:00 Hrs
Printer Print Email Email
NEW DELHI: IndiaÂ’s largest exporter of drugs, Ranbaxy Laboratories, on Wednesday said it will take some more of its products under development for trials to the United States, Britain and Canada.

Ranbaxy, which recently tied up with Schwarz Pharma AG for development of its new drug RBX 2258 for the treatment of benign prostatic hyperplasic, said it is considering taking some drugs under development for trials in the US and the UK.

“We have five to six products under various phases of clinical trials and we will take some of them to the US and UK,” Ranbaxy CEO and managing director D S Brar said.





Experts on SiliconIndia
Santhosh  K
Sr. Soft. Engg.
Oracle India
Nehal Vyas
Sr. Team Lead
Cyberoam Tech.
Rani Malli
Sr. Director
Philips
Sr. Executive
ISB
Vijay Balkrishna Konduskar
Business Consultant
Imans Web Tech
Dr L P  Sharma
Technical Director
NIC
Reena Khanna
Founder
Solitaireworld
Dellas  Asse
sys-network admin
Computer Station
Write your comment now
Submit Reset
SPOTLIGHT